Drug intelligence / Profile preview

Heptorax DS

Development stage: Unknown
Lead developer: Rax Health Care
Administration: Oral

Overview

Heptorax DS is an Ayurvedic/traditional formulation developed and marketed by Rax Health Care Private Limited, an India-based pharmaceutical company. Available in multiple oral dosage forms including syrup, drops, and capsules, the product is positioned within the company's Ayurvedic product range. While the specific herbal composition and molecular targets are not publicly disclosed, the nomenclature (using the 'Hepto-' prefix) indicates that the product is intended for the management of liver-related conditions and hepatoprotection. Rax Health Care operates primarily as a pharmaceutical trader and wholesaler, and Heptorax DS is one of its proprietary traditional health products.

Brand names: Heptorax DSHeptorax
Other names: Heptorax DS SyrupHeptorax DS DropHeptorax DS Capsule

Beyond the preview

Go deeper on Heptorax DS.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heptorax DS.

Explore the full profile